Pharmaceuticals: Women's group attack appointment of FDA acting commissioner

Karen Malec, president of the Coalition on Abortion/Breast Cancer, has slammed (and that's an understatement!) the appointment of Andrew Von Eschenbach, as acting commissioner of the U.S. Food and Drug Administration (FDA).

"Ladies, take cover.. The FDA had a commissioner who could resist political pressure. His abrupt resignation after two months on the job creates the impression that the Bush Administration couldn't take the heat from the abortion and the pharmaceutical industries.

The industries want Plan B (morning-after pill) made available for over-the-counter sales. Von Eschenbach is no friend of women. He's a friend of the anti-woman abortion and pharmaceutical industries.

Von Eschenbach, director of the U.S. National Cancer Institute (NCI), can be relied upon to put in the 'political fix' for business interests, just as he and his subordinates did with their phony workshop on the abortion-cancer link."